AB
Accipiter Biosciences Inc.
SEC filingBiotechnology · Seattle, WA
Amount raised$10.5Msold at filing
Total offering$10.5M
Investors in the raise9count reported to the SEC
FiledJul 28, 2026first sale Jul 21, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Randall SchatzmanDirector
Matthew BickExecutive Officer, Director, Promoter
Hector De Jesus Rincon AranoExecutive Officer, Director, Promoter
Javier CastellanosExecutive Officer, Director, Promoter
Jose Antonio Mesa CejudoDirector
William CanestaroExecutive Officer
Heather RedmanDirector
Executive officers, directors and promoters as listed on the Form D.